Bufei Huoxue capsule attenuates COPD-related inflammation and regulates intestinal microflora, metabolites

• Main Authors: Yuanyuan Li (Author), Jiali Chen (Author), Yue Xing (Author), Jian Wang (Author), Qiuling Liang (Author), Jiamin Zeng (Author), Siyi Wang (Author), Qiong Yang (Author), Jianing Lu (Author), Jieying Hu (Author), Wenju Lu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Bufei Huoxue capsule (BFHX) is widely used for the clinical treatment of chronic obstructive pulmonary disease (COPD) in China.Objectives: The aim of this study is to explore the effects on COPD and the underlying mechanism of BFHX.The process and methods: In this study, we established a...